Skip to content

Journal · Rheumatology · Updated 15 November 2026

Nature Reviews Rheumatology

Read Nature Reviews Rheumatology reviews on DeepDyve. No university library needed.

Nature Reviews Rheumatology, published by Springer Nature (Nature Portfolio), is a review journal covering rheumatic diseases, under its current title since 2009. Its reviews range from rheumatoid arthritis, lupus and osteoarthritis to the immune pathways behind inflammatory disease and the treatments that target them. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.

Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.

Personal plans aren’t for business use. Reading for work? See Enterprise.

Cover of Nature Reviews Rheumatology
November 2026 issue

Nature Reviews Rheumatology at a glance

Full title
Nature Reviews Rheumatology
Abbreviation (NLM)
Nat Rev Rheumatol
Publisher
Springer Nature (Nature Portfolio)
Print ISSN
1759-4790
Online ISSN (eISSN)
1759-4804
Current title since
2009
Subjects
Rheumatology
Access model
Subscription

Ways to access Nature Reviews Rheumatology

Nature Reviews Rheumatology is a subscription journal. To read its articles, look for a preprint or the authors’ manuscript, check a library, or read them on DeepDyve.

  1. Preprints. Nature Reviews Rheumatology encourages authors to post preprints of their research on servers such as arXiv or bioRxiv. A preprint can differ from the published paper.
  2. The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors make their accepted manuscript public 6 months after publication, on a personal website or in a repository such as PubMed Central.
  3. NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
  4. A library. Your university, hospital or public library may subscribe to Nature Reviews Rheumatology. Check its journal list and whether it offers remote access.
  5. DeepDyve. Read Nature Reviews Rheumatology articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.

Sources: Springer Nature self-archiving policy; Nature Portfolio preprint policy; NIH Public Access Policy.

Impact factor and metrics

Nature Reviews Rheumatology’s 2025 Journal Impact Factor is 33.7, and its 5-year Impact Factor is 40.7.

33.7

Journal Impact Factor (2025)

40.7

5-year Impact Factor (2025)

6.768

SCImago Journal Rank (2025)

12 days

Median time to first editorial decision

93 days

Median time from submission to acceptance

Source: Springer Nature journal metrics for Nature Reviews Rheumatology. Impact Factor from Clarivate Journal Citation Reports.

Recent Nature Reviews Rheumatology research worth reading

Published April to August 2026. Summaries describe what the authors report.

  1. LitStreamImmunology · IL-1 cytokines

    Advances in targeting IL-1 family cytokines for the treatment of inflammatory diseases

    This review covers the IL-1 family of pro-inflammatory cytokines, including how their activity is controlled by proteolytic processing, endogenous inhibitors, decoy receptors and receptor antagonists, how disruption of that balance underlies inflammatory diseases, and the approved and developing therapies that target these cytokines.

    Nature Reviews Rheumatology, August 2026 · DOI 10.1038/s41584-026-01395-1

  2. LitStreamRheumatology · Rheumatoid arthritis

    Diagnostic, prognostic and therapeutic biomarkers in rheumatoid arthritis

    This review covers genetic, protein, imaging and multi-omics biomarkers that could refine the diagnosis of rheumatoid arthritis, predict its course and guide treatment choices, along with biomarker work on related conditions including cardiovascular disease, interstitial lung disease, osteoporosis and malignancy.

    Szekanecz et al. · Nature Reviews Rheumatology, published online June 15, 2026 · DOI 10.1038/s41584-026-01391-5

  3. LitStreamRheumatology · Lupus

    Germinal-centre and extrafollicular B cell pathways in systemic lupus erythematosus

    This review covers how autoreactive B cells in systemic lupus erythematosus are directed into germinal-centre or extrafollicular pathways, describing the two as complementary sources of autoreactive effector cells, and the challenge of developing therapies that selectively target pathogenic B cell subsets.

    Zhu et al. · Nature Reviews Rheumatology, published online April 7, 2026 · DOI 10.1038/s41584-026-01365-7

  4. LitStreamRheumatology · Lupus and pregnancy

    Fertility, pregnancy and lactation in women with systemic lupus erythematosus

    This review covers pregnancy in women with systemic lupus erythematosus, including the higher risk of maternal complications and adverse fetal outcomes, the risk factors for flares such as active disease at conception and a history of lupus nephritis, and the role of preconception counselling and multidisciplinary management.

    Bultink et al. · Nature Reviews Rheumatology, published online April 7, 2026 · DOI 10.1038/s41584-026-01366-6

  5. LitStreamRheumatology · Osteoarthritis

    The gut–joint axis in osteoarthritis

    This review covers the gut-joint axis in osteoarthritis, describing how gut microbiota dysbiosis can impair gut barrier integrity and intestinal immunity and promote low-grade inflammation, and the authors note that evidence for treatments targeting this axis remains limited.

    Wei et al. · Nature Reviews Rheumatology, published online May 7, 2026 · DOI 10.1038/s41584-026-01378-2

See every Nature Reviews Rheumatology article on DeepDyve

Questions about Nature Reviews Rheumatology

How can I read Nature Reviews Rheumatology articles without a subscription?

For subscription articles, Springer Nature lets authors make their accepted manuscript public 6 months after publication, on a personal website or in a repository such as PubMed Central. Your library may also subscribe. DeepDyve lets you read Nature Reviews Rheumatology articles online for $59 a month or $499 a year after a free first month.

What is the abbreviation for Nature Reviews Rheumatology?

Nature Reviews Rheumatology’s NLM (PubMed) abbreviation is Nat Rev Rheumatol.

What is the ISSN of Nature Reviews Rheumatology?

The print ISSN is 1759-4790 and the online ISSN is 1759-4804.

Is Nature Reviews Rheumatology open access?

Nature Reviews Rheumatology articles are published under the subscription model; none of the 112 articles it published from January 1 to November 14, 2026 carry a Creative Commons license in Crossref.

What is the impact factor of Nature Reviews Rheumatology?

Nature Reviews Rheumatology’s Journal Impact Factor is 33.7 (2025), and its 5-year Impact Factor is 40.7, according to Springer Nature’s published metrics.

Nature Reviews Rheumatology articles on DeepDyve are licensed from Springer Nature. Journal facts as of 15 November 2026.

Start reading Nature Reviews Rheumatology today

One month free, then less than $2 a day. Nature Reviews Rheumatology, plus millions of articles from thousands of journals.

Start free month

Like this: